MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq:EXAS), a company focused on the early detection and prevention of colon cancer, is pleased to welcome Daniel J. Levangie, Lionel N. Sterling and David A. Thompson to the company’s board of directors.
